Associations Between Pulmonary Artery Catheter Use and Outcomes After Cardiac Surgery: An Entropy-Balanced Cohort Study.

Luke A Perry,Sashritha Peiris,Noah Greifer,Alexandra Karamesinis,Lisa Q Rong,Mario Gaudino,Julian A Smith,Andrew Silvers,Jayme Bennetts,Reny Segal,Marco Larobina,Rinaldo Bellomo,Lachlan F Miles
{"title":"Associations Between Pulmonary Artery Catheter Use and Outcomes After Cardiac Surgery: An Entropy-Balanced Cohort Study.","authors":"Luke A Perry,Sashritha Peiris,Noah Greifer,Alexandra Karamesinis,Lisa Q Rong,Mario Gaudino,Julian A Smith,Andrew Silvers,Jayme Bennetts,Reny Segal,Marco Larobina,Rinaldo Bellomo,Lachlan F Miles","doi":"10.1213/ane.0000000000008198","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nPulmonary artery catheters are used widely in cardiac surgery despite conflicting associations with patient outcomes. We evaluated the associations between pulmonary artery catheter use and clinical outcomes following cardiac surgery using a large cohort of patients treated at a US academic center.\r\n\r\nMETHODS\r\nWe performed a retrospective entropy-balanced cohort study of consecutive adults undergoing cardiac surgery from a single tertiary center in Boston, Massachusetts, from 2008 to 2022. We used entropy balancing to achieve exact covariate balance on prespecified baseline characteristics and then estimated the average treatment effect of pulmonary artery catheter use on clinical and mechanistic outcomes. The primary outcome was mortality measured 90 days after surgery. Secondary outcomes were acute kidney injury, hospital and intensive care unit (ICU) length of stay, time in postoperative organ dysfunction measured at 7 days, prolonged inotrope use (>4 hours), significant peak vasopressor requirement (>0.1 μg/kg/min in norepinephrine equivalents), net fluid balance at 24 hours, number of fluid boluses administered, volume of allogeneic red blood cells transfused, and total duration of mechanical ventilation.\r\n\r\nRESULTS\r\nWe included 10,044 patients, of whom 5850 (58.2%) were managed with a pulmonary artery catheter. Pulmonary artery catheter use was not associated with 90-day mortality (risk ratio [RR], 0.966; 95% confidence interval [CI], 0.719-1.30; P =.816) nor in-hospital mortality (RR, 0.921; 95% CI, 0.632-1.34; P =.670). There was no between-group difference in hospital length of stay (median difference [MD], 0.050 days; 95% CI, 0.0477-0.148; P =.269), but patients managed with a pulmonary artery catheter had greater ICU length of stay (MD = 13.1 hours; 95% CI, 9.74-16.4; P <.001). Pulmonary artery catheters were also associated with increased incidence of acute kidney injury (RR, 1.12; 95% CI, 1.07-1.17; P <.001). Patients who received a pulmonary artery catheter were more likely to have prolonged inotrope requirements (RR, 4.13; 95% CI, 3.42-4.98; P <.001), significant vasopressor requirements (RR, 1.37; 95% CI, 1.28-1.46; P <.001), higher positive fluid balances (MD, 566 mL; 95% CI, 453-678; P <.001), higher volumes of allogeneic RBCs transfused (MD, 226 mL; 95% CI, 183-269; P <.001), higher time in postoperative organ dysfunction (MD, 3.96 hours; 95% CI, 3.01-4.90; P <.001), and longer durations of mechanical ventilation (MD, 11.3 hours; 95% CI, 7.33-15.2; P <.001).\r\n\r\nCONCLUSIONS\r\nIn a large entropy-balanced cohort study of adults undergoing cardiac surgery, pulmonary artery catheter use was not associated with mortality, but was linked with a higher treatment intensity and longer ICU stay.","PeriodicalId":7799,"journal":{"name":"Anesthesia & Analgesia","volume":"22 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia & Analgesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1213/ane.0000000000008198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Pulmonary artery catheters are used widely in cardiac surgery despite conflicting associations with patient outcomes. We evaluated the associations between pulmonary artery catheter use and clinical outcomes following cardiac surgery using a large cohort of patients treated at a US academic center. METHODS We performed a retrospective entropy-balanced cohort study of consecutive adults undergoing cardiac surgery from a single tertiary center in Boston, Massachusetts, from 2008 to 2022. We used entropy balancing to achieve exact covariate balance on prespecified baseline characteristics and then estimated the average treatment effect of pulmonary artery catheter use on clinical and mechanistic outcomes. The primary outcome was mortality measured 90 days after surgery. Secondary outcomes were acute kidney injury, hospital and intensive care unit (ICU) length of stay, time in postoperative organ dysfunction measured at 7 days, prolonged inotrope use (>4 hours), significant peak vasopressor requirement (>0.1 μg/kg/min in norepinephrine equivalents), net fluid balance at 24 hours, number of fluid boluses administered, volume of allogeneic red blood cells transfused, and total duration of mechanical ventilation. RESULTS We included 10,044 patients, of whom 5850 (58.2%) were managed with a pulmonary artery catheter. Pulmonary artery catheter use was not associated with 90-day mortality (risk ratio [RR], 0.966; 95% confidence interval [CI], 0.719-1.30; P =.816) nor in-hospital mortality (RR, 0.921; 95% CI, 0.632-1.34; P =.670). There was no between-group difference in hospital length of stay (median difference [MD], 0.050 days; 95% CI, 0.0477-0.148; P =.269), but patients managed with a pulmonary artery catheter had greater ICU length of stay (MD = 13.1 hours; 95% CI, 9.74-16.4; P <.001). Pulmonary artery catheters were also associated with increased incidence of acute kidney injury (RR, 1.12; 95% CI, 1.07-1.17; P <.001). Patients who received a pulmonary artery catheter were more likely to have prolonged inotrope requirements (RR, 4.13; 95% CI, 3.42-4.98; P <.001), significant vasopressor requirements (RR, 1.37; 95% CI, 1.28-1.46; P <.001), higher positive fluid balances (MD, 566 mL; 95% CI, 453-678; P <.001), higher volumes of allogeneic RBCs transfused (MD, 226 mL; 95% CI, 183-269; P <.001), higher time in postoperative organ dysfunction (MD, 3.96 hours; 95% CI, 3.01-4.90; P <.001), and longer durations of mechanical ventilation (MD, 11.3 hours; 95% CI, 7.33-15.2; P <.001). CONCLUSIONS In a large entropy-balanced cohort study of adults undergoing cardiac surgery, pulmonary artery catheter use was not associated with mortality, but was linked with a higher treatment intensity and longer ICU stay.
心脏手术后肺动脉导管使用与预后之间的关系:一项熵平衡队列研究。
背景肺动脉导管在心脏手术中广泛应用,尽管与患者预后存在矛盾。我们评估了肺动脉导管使用与心脏手术后临床结果之间的关系,使用了在美国学术中心接受治疗的大队列患者。方法:我们对2008年至2022年在马萨诸塞州波士顿的一个三级中心连续接受心脏手术的成年人进行了一项回顾性熵平衡队列研究。我们使用熵平衡来实现预先设定的基线特征的精确协变量平衡,然后估计肺动脉导管使用对临床和机械结果的平均治疗效果。主要终点是术后90天的死亡率。次要结局是急性肾损伤、住院和重症监护病房(ICU)住院时间、术后器官功能障碍时间(7天)、肌力药物使用时间延长(4小时)、血管加压素需要量显著峰值(去甲肾上腺素当量>0.1 μg/kg/min)、24小时净体液平衡、给药次数、输注异体红细胞量和机械通气总时间。结果纳入10044例患者,其中5850例(58.2%)采用肺动脉导管治疗。肺动脉导管使用与90天死亡率(风险比[RR], 0.966; 95%可信区间[CI], 0.719-1.30; P = 0.816)和住院死亡率(RR, 0.921; 95% CI, 0.632-1.34; P = 0.670)无关。两组间住院时间无差异(中位差异[MD], 0.050天;95% CI, 0.0477-0.148; P = 0.269),但采用肺动脉导管治疗的患者在ICU的住院时间更长(MD = 13.1小时;95% CI, 9.74-16.4; P < 0.001)。肺动脉导管也与急性肾损伤发生率增加相关(RR, 1.12; 95% CI, 1.07-1.17; P <.001)。接受肺动脉导管的患者更有可能有延长的肌力需求(RR, 4.13, 95% CI, 3.42-4.98, P < 0.001)、显著的血管高压需求(RR, 1.37, 95% CI, 1.28-1.46, P < 0.001)、较高的阳性体液平衡(MD, 566 mL, 95% CI, 453-678, P < 0.001)、较高的异体红细胞输注量(MD, 226 mL, 95% CI, 183-269, P < 0.001)、较高的术后器官功能障碍时间(MD, 3.96小时,95% CI, 3.01-4.90;P < 0.001),机械通气持续时间较长(MD, 11.3小时;95% CI, 7.33-15.2; P < 0.001)。结论:在一项针对接受心脏手术的成人的大型熵平衡队列研究中,肺动脉导管的使用与死亡率无关,但与更高的治疗强度和更长的ICU住院时间有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书